EP Patent

EP3720433B1 — Bis-choline tetrathiomolybdate for treating wilson disease

Assigned to Alexion Pharmaceuticals Inc · Expires 2022-02-02 · 4y expired

What this patent protects

Patent listed against paltusotine-hydrochloride.

Drugs covered by this patent

paltusotine-hydrochloride (PALTUSOTINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP3720433B1
Jurisdiction: EP
Classification: —
Expires: 2022-02-02
Drug substance claim: No
Drug product claim: No
Assignee: Alexion Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.